BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8627208)

  • 1. The Papanicolaou smear: its value and limitations.
    Lieu D
    J Fam Pract; 1996 Apr; 42(4):391-9. PubMed ID: 8627208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
    Liao SY; Stanbridge EJ
    Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic correlation of the unsatisfactory Papanicolaou smear.
    Ransdell JS; Davey DD; Zaleski S
    Cancer; 1997 Jun; 81(3):139-43. PubMed ID: 9196011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant.
    Uyar DS; Eltabbakh GH; Mount SL
    Gynecol Oncol; 2003 May; 89(2):227-32. PubMed ID: 12713984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papanicolaou smear findings in solid-organ transplant recipients compared with normal subjects according to the Bethesda 2001 system.
    Ok Atılgan A; Tepeoğlu M; Haberal AN; Durukan E; Kuşcu E; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():219-22. PubMed ID: 25894158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of repeat Pap smear at the time of colposcopy.
    Zardawi IM; Rode JW
    Acta Cytol; 2002; 46(3):495-8. PubMed ID: 12040643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role Of Papanicolaou Smear In Mapping Out Cervical Epithelial Morphology In Women With Infertility: Modified Bethesda Classification.
    Javed S; Huma Z; Sadaf A; Hameed N; Sherin F; Momin N
    J Ayub Med Coll Abbottabad; 2019; 31(4):558-562. PubMed ID: 31933311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observer variation in cytologic grading for cervical dysplasia of Papanicolaou smears with the PAPNET testing system.
    Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; van den Tweel JG
    Cancer; 1999 Aug; 87(4):178-83. PubMed ID: 10455204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
    Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
    Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of false-negative papanicolaou smears: a prospective study using screening colposcopy in addition to cytology.
    Mannino JR
    J Am Osteopath Assoc; 1998 Oct; 98(10):542-6. PubMed ID: 9821735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The determination of Papanicolaou smear adequacy using a semiquantitative method to evaluate cellularity.
    Valente PT; Schantz HD; Trabal JF
    Diagn Cytopathol; 1991; 7(6):576-80. PubMed ID: 1769285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA cytometry confirms the utility of the Bethesda system for the classification of Papanicolaou smears.
    Bollmann R; Bollmann M; Henson DE; Bodo M
    Cancer; 2001 Jun; 93(3):222-8. PubMed ID: 11391611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liqui-Prep® versus conventional Papanicolaou smear to detect cervical cells abnormality by split-sample technique: a randomized double-blind controlled trial.
    Jesdapatarakul S; Tangjitgamol S; Nguansangiam S; Manusirivithaya S
    Diagn Cytopathol; 2011 Jan; 39(1):22-7. PubMed ID: 20063407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England.
    Mount SL; Papillo JL
    Pediatrics; 1999 Mar; 103(3):539-45. PubMed ID: 10049953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bethesda system and evaluation of abnormal pap smears.
    Nguyen HN; Nordqvist SR
    Semin Surg Oncol; 1999; 16(3):217-21. PubMed ID: 10225298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pap smears. Do them right and every year--forever!
    Gall SA
    Postgrad Med; 1989 May; 85(6):235-9. PubMed ID: 2710727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
    Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
    Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of cervical intraepithelial neoplasia and cervical carcinoma by microsatellite analysis of Papanicolaou smears.
    Rha SH; Dong SM; Jen J; Nicol T; Sidransky D
    Int J Cancer; 2001 Aug; 93(3):424-9. PubMed ID: 11433409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Abnormal Pap Smear with Occult Cervical Stromal Invasion in Patients with Endometrial Cancer.
    Khumthong K; Aue-Aungkul A; Kleebkaow P; Chumworathayi B; Temtanakitpaisan A; Nhokaew W
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2847-2850. PubMed ID: 31554386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pap smear revisited. Controversies and recent developments.
    Zuna RE
    Postgrad Med; 1984 Nov; 76(6):36-40, 42-3, 46. PubMed ID: 6494079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.